Exposure-adjusted Safety Analyses of the VISION Phase 3 Trial of 177Lu-Psma-617 in Patients with Metastatic Castration-Resistant Prostate Cancer.
Journal of Clinical Oncology（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined